TXA effective in reducing blood loss and transfusion in TKA vs. routine hemostasis
Topical and intravenous tranexamic acid reduce blood loss compared to routine hemostasis in total knee arthroplasty: a multicenter, randomized, controlled trialArch Orthop Trauma Surg. 2015 Jul;135(7):1017-25
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
150 patients undergoing primary total knee arthroplasty (TKA) were randomized to receive 1 g of topical tranexamic acid (TXA), 2 g of intravenous TXA, or routine hemostasis. The purpose of the study was to determine which TXA administration modality more effectively reduced total blood loss 24 post-surgery and the need for subsequent blood transfusions. Findings indicated that although a significa...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE